ADHD Ultimate Panel
The ADHD Ultimate Panel quantifies micronutrients (zinc, magnesium, copper, iron), omega-3 fatty acids, vitamin D, homocysteine, hs-CRP, TSH, and HbA1c to identify nutritional, metabolic, and inflammatory contributors in patients with attention-deficit/hyperactivity disorder. It is a functional-medicine tool, not a diagnostic test, used to guide targeted supplementation and lifestyle intervention.
11
Biomarkers
Blood (whole blood)
Sample
7–10 business days
Turnaround
No
Fasting
What is the ADHD Ultimate Panel test?
The ADHD Ultimate Panel is a comprehensive laboratory assessment designed to identify nutritional, metabolic, and inflammatory contributors that may underlie or exacerbate attention-deficit/hyperactivity disorder symptoms. It is not a diagnostic test for ADHD — diagnosis remains clinical, based on history, symptom criteria, and functional impairment — but rather a functional-medicine tool to uncover modifiable biological factors such as micronutrient deficiencies, oxidative stress, inflammation, and metabolic dysregulation. Practitioners order this panel when seeking a root-cause or systems-biology perspective on a patient with established or suspected ADHD, particularly in integrative, naturopathic, or functional-medicine settings where nutritional and lifestyle interventions are prioritised. The panel combines markers of trace-element status (zinc, copper, magnesium, iron), omega-3 fatty acids, vitamin D, methylation (homocysteine), systemic inflammation (hs-CRP), thyroid function, and glycaemic control. Interpretation is individualised, and abnormalities guide targeted supplementation, dietary modification, or further investigation rather than serving as standalone diagnostic criteria.
What does the ADHD Ultimate Panel test measure?
Zinc is an essential trace element required for over 300 metalloenzymes involved in neurotransmitter synthesis, synaptic plasticity, and neuronal signalling. It modulates dopamine and glutamate receptor function and is concentrated in hippocampal and cortical regions critical to attention and executive function. Serum zinc represents only a small fraction of total-body stores and fluctuates with inflammation, albumin status, and recent intake.
Low zinc has been associated with attention deficits, hyperactivity, and impulsivity in some observational studies, though the relationship is complex and not consistently reproduced. Zinc supplementation trials in ADHD show mixed outcomes. Serum zinc is an indirect marker of status and should be interpreted alongside clinical context and dietary history.
Magnesium is the second most abundant intracellular cation and serves as a cofactor for enzymes regulating energy production, protein synthesis, and neurotransmitter release. It modulates NMDA receptor activity, influences GABAergic and dopaminergic pathways, and stabilises neuronal membranes. Serum magnesium reflects less than 1% of total-body stores, so deficiency can exist despite normal serum concentrations.
Magnesium deficiency has been linked to irritability, attention difficulties, and hyperactivity in children, and supplementation is commonly recommended in integrative ADHD protocols. However, serum magnesium is an insensitive marker of tissue status, and the evidence base for benefit in ADHD remains limited.
Copper is an essential cofactor for enzymes involved in neurotransmitter synthesis (dopamine beta-hydroxylase, tyrosinase), mitochondrial respiration, and antioxidant defence. Most circulating copper is bound to ceruloplasmin. Imbalances affect catecholamine production, iron metabolism, and oxidative stress pathways relevant to neuropsychiatric function.
Both deficiency and excess copper have been proposed to influence attention, mood, and behaviour. Some functional practitioners interpret elevated copper or a high copper:zinc ratio as a contributor to hyperactivity and anxiety, though robust clinical evidence for these associations in ADHD is lacking.
Ferritin is the primary intracellular iron-storage protein; serum ferritin generally correlates with total-body iron stores, though it is also an acute-phase reactant and can be elevated in inflammation, infection, or liver disease independently of iron status. Iron is required for dopamine synthesis, myelination, and mitochondrial function in the central nervous system.
Low ferritin (<30 ng/mL, or <50 ng/mL in some functional protocols) has been associated with restless legs, sleep disturbance, and inattention in children and adults, and iron supplementation in iron-deficient individuals may improve ADHD symptoms. Ferritin is the most accessible marker of iron status, but interpretation requires clinical context.
25-Hydroxyvitamin D is the major circulating form of vitamin D and the best marker of vitamin D status. It is hydroxylated in the kidney to the active hormone calcitriol, which acts through the vitamin D receptor expressed widely in the brain, influencing dopamine synthesis, neuroprotection, and immune modulation.
Vitamin D deficiency is common and has been associated with mood disorders, cognitive impairment, and, in some studies, ADHD symptoms. Supplementation trials show inconsistent effects on attention or behaviour, suggesting that correction of deficiency is important for general neurodevelopment but not a specific ADHD treatment.
The Omega-3 Index quantifies eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) as a percentage of total red blood cell membrane fatty acids, reflecting long-term dietary intake and tissue incorporation. EPA and DHA are structural components of neuronal membranes and precursors to anti-inflammatory mediators; DHA is especially concentrated in the brain and retina.
Meta-analyses of omega-3 supplementation in ADHD show modest benefits, particularly for inattention, though effect sizes are small and inconsistent. The Omega-3 Index provides an objective measure of status that may help guide supplementation, but it is not diagnostic and does not predict treatment response in an individual.
Homocysteine is an intermediate in methionine metabolism, dependent on folate, vitamins B6 and B12, and betaine for remethylation or transsulphuration. Elevated homocysteine reflects impaired one-carbon metabolism and is a marker of oxidative stress, endothelial dysfunction, and, in extreme cases, neurotoxicity.
Mild hyperhomocysteinaemia has been proposed as a marker of methylation insufficiency and oxidative stress in neurodevelopmental and psychiatric disorders, though direct evidence linking it to ADHD pathophysiology is limited. Elevated homocysteine may identify B-vitamin deficiencies amenable to supplementation.
C-reactive protein is an acute-phase reactant synthesised by the liver in response to IL-6 and other inflammatory cytokines. High-sensitivity assays detect low-grade chronic inflammation associated with metabolic and cardiovascular disease. Neuroinflammation and peripheral inflammatory markers have been investigated as potential contributors to psychiatric and neurodevelopmental disorders.
Elevated hs-CRP has been observed in some cohorts of children and adults with ADHD, though findings are inconsistent and causality is not established. It is included in comprehensive functional panels as a general marker of systemic inflammation, not as a diagnostic or specific marker of ADHD.
TSH is secreted by the anterior pituitary in response to hypothalamic TRH and regulates thyroid hormone synthesis and release. It is the most sensitive first-line marker of thyroid dysfunction, rising in primary hypothyroidism and falling in hyperthyroidism. Thyroid hormones are critical for neurodevelopment, myelination, and regulation of metabolism and arousal.
Both overt and subclinical thyroid dysfunction can present with inattention, cognitive slowing, or behavioural changes that overlap with or exacerbate ADHD symptoms. TSH screening is standard in the evaluation of attention and behavioural concerns to exclude a thyroid contribution.
HbA1c reflects glycation of haemoglobin over the preceding 2–3 months and is used to diagnose and monitor diabetes. Chronic hyperglycaemia and insulin resistance affect brain glucose metabolism, neurotransmitter synthesis, and vascular health, with implications for cognition and mood.
Insulin resistance and dysglycaemia are not direct causes of ADHD but are more prevalent in individuals with ADHD and may exacerbate symptoms through effects on energy regulation, inflammation, and sleep. HbA1c is included as a metabolic screen.
The copper:zinc ratio is a calculated index reflecting the balance between these two trace elements, which interact in enzymatic pathways, immune function, and oxidative stress regulation. Interpretation is complicated by the fact that both are influenced by inflammation, dietary intake, and binding proteins.
An elevated copper:zinc ratio has been proposed as a marker of oxidative stress, oestrogen dominance, or pyrrole disorder in functional medicine, and some practitioners link it to hyperactivity and anxiety. However, the ratio is not validated as a diagnostic or therapeutic target in ADHD, and reference ranges are inconsistent.
Why is the ADHD Ultimate Panel test ordered?
- Integrative or functional-medicine evaluation of children, adolescents, or adults with clinically diagnosed ADHD who have not responded adequately to first-line behavioural or pharmacological interventions
- Assessment of patients with ADHD and comorbid metabolic concerns (obesity, insulin resistance, prediabetes) or inflammatory conditions that may worsen attention and executive-function deficits
- Screening for nutritional deficiencies in individuals with ADHD and restricted diets, gastrointestinal symptoms, or malabsorption that may impair micronutrient status
- Investigation of fatigue, sleep disturbance, or mood symptoms in ADHD that may reflect iron deficiency, thyroid dysfunction, or vitamin D insufficiency rather than primary attention pathology
- Pre-intervention baseline in patients pursuing a supplement-based or dietary protocol for ADHD, to objectively document status and guide dosing
- Follow-up monitoring of patients on high-dose micronutrient supplementation or omega-3 therapy to confirm biochemical correction and avoid toxicity
- Work-up of suspected pyrrole disorder, methylation defects, or oxidative stress in functional-psychiatry frameworks, where copper:zinc ratio and homocysteine are used as proxy markers
- Exclusion of medical mimics (hypothyroidism, anaemia, hyperglycaemia) in the evaluation of new-onset inattention or behavioural change
Sample collection and turnaround
Sample type
Blood (whole blood)
Fasting required
No
Collection method
Venipuncture at patient service centre
Turnaround
7–10 business days
Collection notes
Phlebotomy required. Multiple analytes are measured from a single whole-blood or serum/plasma collection. Practitioners may recommend a several-week washout from supplements for baseline status, though this is not mandatory. Avoid vigorous exercise before the draw. Note any current medications, supplements, and phase of menstrual cycle or hormonal contraceptive use, as these influence copper, zinc, and ferritin.
Specimen requirements
Whole blood for Omega-3 Index (red blood cell fatty-acid analysis) and standard serum or plasma tubes for the remaining analytes. Separate and process promptly; some trace elements are sensitive to haemolysis. Minimum volumes and specific tube types are specified by Access Medical Laboratories at the time of ordering.
What can affect ADHD Ultimate Panel results?
Ferritin and hs-CRP are acute-phase reactants and rise with infection or inflammation, potentially masking true iron deficiency or inflating inflammatory markers; copper also rises as an acute-phase protein, while zinc may fall.
Serum zinc, magnesium, vitamin D, and omega-3 levels reflect recent intake and supplementation; for accurate baseline status, practitioners may recommend a washout period of several weeks before testing, though this is not always practical.
Oestrogen increases ceruloplasmin and serum copper, raising both copper levels and the copper:zinc ratio without reflecting true tissue copper excess; interpretation in women on hormonal contraception or in pregnancy requires caution.
Red cells contain magnesium, zinc, and other intracellular constituents; haemolysed samples can spuriously alter trace-element and electrolyte results and should be rejected.
Serum zinc and magnesium show modest diurnal and meal-related fluctuations; fasting is not required but may reduce variability. Omega-3 Index reflects long-term intake and is not acutely affected by a single meal.
Kidney disease alters vitamin D metabolism and trace-element excretion; liver disease affects synthesis of binding proteins (albumin, ceruloplasmin) and metabolism of homocysteine, complicating interpretation of multiple analytes in this panel.
What do ADHD Ultimate Panel results mean?
Elevated
Elevated copper, copper:zinc ratio, homocysteine, hs-CRP, TSH, or HbA1c — Copper and copper:zinc elevations are common in inflammatory states, oestrogen exposure, and as acute-phase responses; isolated elevations without corroborating clinical or dietary context should not drive aggressive chelation or supplementation. Homocysteine >15 µmol/L warrants evaluation for B-vitamin deficiencies (folate, B12, B6) and, if very high, genetic polymorphisms (MTHFR, CBS). hs-CRP >3 mg/L suggests systemic inflammation; rule out infection, obesity, metabolic syndrome, or autoimmune disease. Elevated TSH indicates hypothyroidism, which can present with inattention and cognitive slowing; confirm with free T4. HbA1c ≥5.7% signals prediabetes or diabetes, which may exacerbate ADHD symptoms through metabolic and vascular pathways and warrants metabolic intervention.
Normal
Results within population reference ranges do not exclude contributory nutritional or metabolic factors — serum magnesium is insensitive to intracellular depletion, and individuals may benefit from repletion trials even with normal serum levels. Similarly, ferritin in the low-normal range (e.g., 30–50 ng/mL) has been associated with restless legs and inattention in some studies. Interpret results in the context of symptoms, dietary history, and response to supplementation rather than relying solely on laboratory cut-offs.
Reduced
Low zinc, magnesium, ferritin, vitamin D, or Omega-3 Index — Serum zinc <60 µg/dL, magnesium <1.7 mg/dL, ferritin <30 ng/mL (or <50 ng/mL by functional thresholds), 25(OH)D <30 ng/mL, and Omega-3 Index <4% all reflect deficiency or insufficiency and may contribute to attention deficits, hyperactivity, mood dysregulation, or sleep disturbance. Correct with targeted supplementation at evidence-based doses, monitoring for response and avoiding toxicity. Low copper is uncommon and may reflect malabsorption or excessive zinc supplementation, which competitively inhibits copper absorption.
Note: This panel does not diagnose ADHD and is not a substitute for clinical assessment. Many of the markers (copper:zinc ratio, 'optimal' micronutrient ranges, homocysteine thresholds) are used in functional medicine but lack robust validation in ADHD-specific research. Supplementation should be guided by documented deficiencies and clinical response, not by speculative 'optimal' targets. Genetic testing (e.g., MTHFR) is not routinely indicated and should not drive treatment in the absence of biochemical abnormalities. Serial monitoring is appropriate when high-dose supplementation is undertaken, to document correction and avoid toxicity (particularly for fat-soluble vitamins, iron, copper, and zinc).
Frequently asked questions
No. ADHD diagnosis is clinical, based on symptom criteria, history, and functional impairment. This panel identifies modifiable biological factors — nutritional deficiencies, inflammation, metabolic dysregulation — that may contribute to or worsen ADHD symptoms.
How to access the ADHD Ultimate Panel test
The ADHD Ultimate Panel reference page is free and open to all practitioners. Create a free practitioner account to see pricing, save tests to your list, and generate requisition forms. Verification takes 1–2 business days.
Create Free AccountAbout this page
Published: October 7, 2026
Last reviewed: October 7, 2026
- Cortese S, et al. Association between ADHD and obesity: a systematic review and meta-analysis. Am J Psychiatry. (2016)
- Konofal E, et al. Iron deficiency in children with attention-deficit/hyperactivity disorder. Arch Pediatr Adolesc Med. (2004)
- Bloch MH, Qawasmi A. Omega-3 fatty acid supplementation for the treatment of children with attention-deficit/hyperactivity disorder symptomatology: systematic review and meta-analysis. J Am Acad Child Adolesc Psychiatry. (2011)
- Hemamy M, et al. The relationship between vitamin D and attention deficit hyperactivity disorder: a systematic review. Psychiatry Res. (2021)
- Rucklidge JJ, et al. Vitamin-mineral treatment of ADHD in adults: a 1-year naturalistic follow-up. J Atten Disord. (2014)
This content is for licensed healthcare practitioners only and does not constitute medical advice. Clinical decisions should be based on the full clinical picture and not on any single test result.